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1. Introduction 
Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels, and 
include coronary heart disease (CHD), cerebrovascular disease (stroke), raised blood 
pressure (hypertension), peripheral artery disease, rheumatic heart disease, congenital heart 
disease and heart failure. According to the World Health Organization, CVD are the number 
one cause of death globally and claim 17 million lives each year. By 2030, almost 24 million 
people will die from CVD, mainly from heart disease and stroke. These are projected to 
remain the single leading causes of death (World Health Organization. Cardiovascular 
diseases (CVDs). Available from: http://www.who.int/mediacentre/factsheets/fs 
317/en/index.html). In the United States, CVD account for more than one-third (34.3%) of 
deaths annually, and responsible for nearly 3 million Americans reporting disability. The 
costs of CVD are also staggering. In 2010, the total cost including health care services, 
medications and lost productivity, is estimated to be over $503 billion in the United States 
(Centers for Disease Control and Prevention. Heart Disease and Stroke Prevention. 
Addressing the nation’s leading killers: at a glance 2010. Available from: 
http://www.cdc.gov/chronicdisease/resources/publications/AAG/dhdsp.htm). Similarly, 
the National Heart Foundation of Australia reported that CVD are the leading cause of 
mortality and morbidity in Australia, killing one person nearly every 10 minutes (National 
Heart Foundation of Australia. Data and statistics. Available from: http:// 
www.heartfoundation.org.au/information-for-professionals/data-and-statistics). Despite 
improvements over the last few decades, CVD remain as the second largest disease burden 
to our society after cancers. As the population ages, the economic impact of CVD on the 
health care system will become even greater. Tobacco smoking, an unhealthy diet, physical 
inactivity and high alcohol consumption increase the risk of CVD. Indeed, behavioral and 
dietary risk factors are responsible for about 80% of coronary heart disease and 
cerebrovascular disease (World Health Organization. Cardiovascular diseases (CVDs). 
Available from: http://www.who.int/mediacentre/factsheets/fs317/en/index.html).  
Interestingly, both the incidence and mortality rate of CVD are much lower in Japan than 
other countries (Mozaffarian D) which may be attributed to the high consumption of 
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fish/seafood by the Japanese population (Meyer BJ). The fact that fish is abundant in omega-
3 polyunsaturated fatty acids has opened an effective venue to the prevention and treatment 
of this disease by either dietary modifications or pharmacological supplementation. 
Cardiovascular disease is multi-factorial which is associated with factors like hereditary, 
hyperlipidemia, obesity, hypertension, environmental and life style variables like stress, 
smoking, alcohol consumption, etc (Chopra and Wasir 1998). Lipoprotein profile has been 
investigated extensively in recent years, which is deranged in large proportion of coronary 
artery disease (CAD) patients; especially Asians showing a mixed picture of dyslipidemia 
(Vasisht et al, 1990).  Literature survey reveals dyslipidaemic subjects are more prone to 
myocardial infarction, due to increased free radical generation and ischemia as it is a 
conventional risk factor. (Malhotra et al, 2003; Mishra et al, 2005; Ghosh et al, 2006; Patil et al, 
2007; Rajasekhar et al, 2004; Rani et al, 2005; Gomez et al,1996). Lowering of high density 
lipoprotein- cholesterol (HDL-C) is a common phenomenon observed in MI patients 
supported by previous studies (Malhotra et al, 2003; Mishra et al, 2005; Ghosh et al, 2006; 
Patil et al, 2007; Rajasekhar et al, 2004; Rani et al, 2005). High density lipoprotein- cholesterol 
(HDL-c) is the most important independent protective factor for arteriosclerosis which 
underlies coronary heart disease (CHD). High density lipoprotein- cholesterol (HDL-c) 
associated paraoxonase-1 (PON1) enzyme is protective against lipid peroxidation (Singh et 
al, 2007). Numerous cohort studies and clinical trials have confirmed the association 
between a low high density lipoprotein- cholesterol (HDL-c) and increased risk of coronary 
heart disease (CHD). Low density lipoprotein-cholesterol (LDL-C) is considered as the most 
important risk factor of coronary artery disease (CAD). Its oxidized form promotes foam 
cells formation which initiates the process of atherosclerosis by accumulating in sub-
endothelium cells leading to fatty streaks and complex fibro fatty or atheromatous plaques 
formation (Berliner et al, 1995). The oxidation of low-density lipoprotein (LDL) can be 
limited by antioxidant enzyme system, including superoxide dismutase, catalase, 
glutathione peroxidase and antioxidant vitamins C, A, E and other carotenoids. Among the 
endogenous antioxidant system, includes albumin, uric acid, and total bilirubin. Imbalance 
of this reaction either due to excess free radical formation or insufficient removal by 
antioxidants leads to oxidative stress (Frei et al, 1998; Shrinivas et al, 2000; Maritim et al, 
2003).  
Various other risk factors have been identified apart from dyslipidemia are caeruloplasmin, 
C-reactive proteins, Lipoprotein (a), plasma fibrinogen, etc. Since we have encountered 
myocardial infarct patients with normal serum lipid concentration, we conducted a 
prospective case-control study to evaluate the concentration of antioxidant enzymes, degree 
of lipid peroxidation and other risk factors associated with acute myocardial infarction.  
2. Materials and methods 
The prospective case-control study consisted of 165 patients (123 men and 42 women) with 
AMI, admitted to the Intensive Cardiac Care Unit (ICCU), Sharda Hospital, India. The 
diagnosis of AMI was established according to diagnostic criteria: chest pain lasting for ≤3 
hours, electrocardiographic (ECG) changes (ST elevation ≥ 2 mm in at least two leads) and 
elevation in enzymatic activities of serum creatine phosphokinase (CPK) and aspartate 
aminotransferase (AST). The control group consisted of 165 age/sex-matched healthy 
volunteers (123 men and 42 women). The design of this study was pre-approved by the 
www.intechopen.com
 
Cardiovascular Risk Factors in Elderly Normolipidaemic Acute Myocardial Infarct Patients 
 
85 
institutional ethical committee board and informed consent was obtained from the patients 
and controls. Inclusion criteria were patients with a diagnosis of acute myocardial infarction 
(AMI) with normal lipid profile. Patients with diabetes mellitus, renal insufficiency, current 
and past smokers, hepatic disease or taking lipid lowering drugs or antioxidant vitamin 
supplements were excluded from the study. Normolipidemic status was judged by the 
following criteria: LDL≤160 mg/dl; HDL, ≥35 mg/dl; total cholesterol (TC), <200 mg/dl; 
and triglycerides (TG), <150 mg/dl (NCEP, ATP-III, 2001). Ten milliliters of blood was 
collected after overnight fasting for lipid profile assay. For ischemia-modified albumin 
(IscMA) analysis, 2 ml of blood was collected from the patients immediately after admission 
to intensive care unit.  
Lipid Profile Total cholesterol (TC), triglyceride (TG) and high density lipoprotein- 
cholesterol (HDL-c) were analyzed enzymatically using kit obtained from Randox 
Laboratories Limited, Crumlin, UK. Plasma low density lipoprotein -cholesterol was 
determined from the values of total cholesterol and high density lipoprotein-cholesterol 
using the following formula: 
( )TGLDL-cholesterol=TC -  - HDL-cholesterol mg/dl
5
 
Other assays - Serum albumin was measured by Bromocresol green binding method (Perry 
et al, 1979).  Serum uric acid was estimated by the method of Brown based on the 
development of a blue color due to tungsten blue as phosphotungstic acid is reduced by uric 
acid in alkaline medium (Brown ,1945). Serum total bilirubin was estimated by the method 
of Jendrassik and Grof (Jendrassik and Grof, 1938).  
The glutathione peroxidase (GPx) activity was determined by the procedure of Paglia and 
Valentine (Paglia and Valentine,1967). Superoxide dismutase (SOD) enzyme activity was 
measured by SOD assay kit using rate of inhibition of 2-(4-indophenyl)-(4-Nitrophenol)-5-
phenyltetrazolium chloride (I.N.T) reduction method modified by Sun et al (Sun et al, 1988). 
Catalase activity was measured spectrophotometrically as described by Beutler (Beutler, 
1984). MDA levels were estimated by thiobarbituric acid (TBA) reaction (Bernheim et al, 
1948).Conjugated diene (CD) levels were measured by Recknagel and Glende method 
(Recknagel and Glende, 1984) with little modification. Caeruloplasmin assay was done by p-
phenylene diamine method (Ravin, 1961). Ischemia-modified albumin (IscMA) 
concentration was determined by addition of a known amount of cobalt (II) to a serum 
sample and measurement of the unbound cobalt (II) by the intensity of colored complex 
formed after reacting with dithiothreitol (DTT) by colorimeter (Libby ,2003). Lipoprotein (a), 
levels were determined by Latex- Enhanced turbidimetric method. Serum paraoxonase was 
estimated using Zeptometrix Assay Kit obtained from Zeptometrix Corp, New York, 14202 
based on the cleavage of phenyl acetate resulting in phenol formation. The rate of formation 
of phenol is measured by monitoring the increase in absorbance at 270 nm at 25°C.  
Estimation of ascorbic acid was carried out by Roe and Kuether method (Roe and Kuether, 
1943). The C-reactive protein were determined using high sensitivity enzyme Immunoassay 
kit manufactured by Life Diagnostics,inc., Catalog Number: 2210. The principle of the assay 
was based on a solid phase enzyme-linked immunosorbent assay (Kumar and Sivakanesan, 
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2008). The plasma fibrinogen was determined using kit which was obtained from TEClot Fib 
Kit 10 Catalog No: 050-500, manufactured by TECO GmbH, Dieselstr. 1, 84088 Neufahrn NB 
Germany (Kumar and Sivakanesan, 2008).  
All chemicals of analytical grade were obtained from Sigma-Aldrich Company, New Delhi.  
3. Results 
Anthropometric parameters in acute myocardial infarction (AMI) patients and control are 
shown in Table 1. Total cholesterol, its ratio to high density lipoprotein -cholesterol 
(TC/HDL-C) and triglyceride were significantly higher in both sexes of patients compared 
with control (Table 2 and 3). The low density lipoprotein –cholesterol (LDL-c) and its ratio to 
high density lipoprotein –cholesterol (LDL-c) (LDL-C/HDL-C) were higher in acute 
myocardial infarction (AMI) subjects than in control (Table-3). The behavioral pattern and 
familial history of cardiovascular disease is presented in Table 4. The distribution of risk 
factors and relative risk according to potential risk factors among cases and controls are 
presented in Table 5 and Table 6. The status of antioxidants and lipid peroxidation are 
shown in Tables 7. All antioxidants were significantly decreased in patients compared with 
controls. In agreement with this serum malondialdehyde (MDA) and conjugated diene (CD) 
were more abundant in patients compared with controls. Ischemia-modified albumin 
(IscMA) levels were also greater in both male and female patients compared with control 
(Table 7).Serum fibrinogen, caeruloplasmin, ischemia- modified albumin and C-reactive 
protein were significantly higher where as arylesterase activity were significantly lowered in 
cases compared with controls ( Table 8). 
 
 Control 
(n=165) 
MI patients 
(n=165) 
P- value (95%CI) 
Age (years) 
Range (years) 
60.5 ± 3.4 
(48-69) 
61.8 ± 3.8 
(48-69) 
0.0037 (61.26- 62.33) 
Height (m) 1.63 ± 0.04 1.64 ± 0.59 0.2919 (1.55-1.72) 
Weight ( kg) 68.34 ± 3.97 72.01 ± 5.37 <0.01 (71.25-72.76) 
BMI ( kg/m2) 25.40 ± 1.20 26.16 ± 1.45 <0.01 (25.95-26.36) 
Waist Circumference (cm) 93.70 ± 3.63 100.77 ± 6.06 <0.01 (99.91-101.62) 
Hip Circumference (cm) 100.01 ± 3.16 105.72 ± 5.23 <0.01 (104.82-106.45) 
Waist-Hip ratio 0.93 ± 0.01 0.95 ± 0.01 <0.001 (0.94-0.95) 
Mid Arm Circumference (cm) 29.70 ± 1.47 30.63 ± 1.87 <0.01 (30.36-30.89) 
Biceps skin fold thickness 
(mm) 
6.95 ± 1.05 7.5 ± 1.38 <0.001 (7.30-7.69) 
Triceps skin fold thickness 
(mm) 
11.97 ± 1.27 12.89 ± 1.69 <0.001 (12.65-13.12) 
Systolic blood pressure 
(mmHg) 
121.06 ± 4.19 134.32 ± 11.65 <0.05 (132.67-135.96) 
Diastolic blood pressure 
(mmHg) 
79.90 ± 3.64 86.04 ± 4.25 <0.05 (85.44-86.63) 
Table 1. Anthropometric data of control and patients (mean ± SD)   
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Variables Controls 
(n=165) 
Patients 
(n=165) 
P-value (95%CI) 
Age 60.55 ± 3.98 61.84 ± 3.80 0.0037( 61.26-62.42) 
Total Cholesterol (mg/dl) 168.58 ± 12.16 186.44 ± 13.95 <0.001(184.31-188.56) 
HDL-Cholesterol (mg/dl) 50.51 ± 6.78 41.27 ± 4.62 <0.001(40.56-41.97) 
Triglycerides (mg/dl) 107.84 ± 11.51 128.96 ± 12.19 <0.001(127.10-130.82) 
LDL-Cholesterol (mg/dl) 83.59 ± 11.95 119.37 ± 14.05 <0.001(17.22-21.51) 
TC: HDL-C 3.39 ± 0.36 4.57 ± 0.58 <0.001(4.48-4.65) 
LDL:HDL-C 1.90 ± 0.31 2.93 ± 0.51 <0.001(2.85-3.00) 
TG: HDL-C 2.17 ± 0.35 3.16 ± 0.49 0.3149(3.086-3.234) 
Table 2. Lipid profile in patients and healthy controls (mean ± SD) 
 
Ratio Controls 
(n=165) 
Patients 
(n=165) 
TC/HDL-C 
2-3 2.90 ± 0.09 
(n=28) 
- 
3-4 3.44 ± 0.25 
(n=129) 
3.70 ± 0.20 
( n=31) 
4-5 4.19 ± 0.22 
(n=8) 
4.53 ± 0.27 
( n=90) 
5-6 - 5.26 ± 0.23 
(n=44) 
TG/HDL-C 
1-2 1.77 ± 0.13 
(n=56) 
- 
2-3 2.38 ± 0.23 
(n=109) 
2.65 ± 0.27 
(n=59) 
3-4 - 3.42 ± 0.26 
(n=99) 
4-5 - 4.22 ± 0.19 
(n=7) 
LDL-C/HDL-C 
1-2 1.71 ± 0.17 
(n=106) 
1.86 ± 0.15 
(n=5) 
2-3 2.23 ± 0.21 
( n=59) 
2.57 ± 0.27 
(n=81) 
3-4 - 3.32 ± 0.21 
(n=74) 
4-5 - 4.11 ± 0.12 
(n=5) 
Table 3. Distribution of Lipid ratios in patients and healthy controls (mean ± SD) 
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   Control Group Study Group 
                                       Yes 
Hyperactive                         
                                        no 
39 
(23.63) 
68 
(41.21) 
126 
(76.36) 
97 
(58.78) 
                                       yes 
Triffle thinker *                    
                                       no 
30 
(18.18) 
99 
(60.00) 
135 
(81.81) 
66 
(40.00) 
                                      yes 
Irrelevant thinker                
                                      No 
50 
(30.30) 
106 
(64.24) 
115 
(69.69) 
59 
(35.75) 
Numbers in parentheses are percent unless mentioned otherwise 
*Triffle thinker: subjects who thinks and worries on unnecessary small things  
Table 4. Behavioral Pattern in AMI patients and control 
 
 AMI Cases ( n=165) Controls ( n= 165) 
Age (y) 61.84 ± 3.80 60.55 ± 3.98 
BMI (kg/m2) 26.16 ± 1.45 25.40 ± 1.20 
Waist-to-hip ratio 0.95 ± 0.11 0.93 ± 0.08a 
Alcohol intake (servings/d) 0.36 ± 0.68 0.15 ± 0.34a 
Physical activity ( MET-min/d)  56.23 ± 123.8 97.83 ± 174.8a 
Current cigarette smokers (%) 14.45 3.6b 
Current bidi smokers (%) 23.67 12.31c 
Family history of MI (%) 37.57 8.48d 
Hypertension (%) 49.09 1.8e 
Alcoholics (%) 47.87 20.60f 
Values are in Mean ± SD  
a,b,c,d,e,f Significantly different from cases (t test for matched data): a,b,c P≤ 0.001, d,e P≤ 0.0001, f P≤ 0.003    
Table 5. Distribution of risk factors among AMI patients and control 
 
 No. of cases 
N 
No. of controls
N 
Age- and sex- 
 adjusted RR 
(95% CI)b 
Multivariate RR 
 (95% CI)c 
Cigarette smoking 
Never smoker 120 136 1.0 1.0 
>10 cigarettes/d 36 6 7.8 (4.9, 13.5) 7.4 (4.3, 15.2) 
Bidi smoking* 
Never smoker 120 136 1.0 1.0 
> 10 bidis/d 49 8 8.2 (5.2, 14.2) 6.5 (3.9, 12.9) 
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BMI (kg/m2) 
20-24.9 30 51 1.0 1.0 
≥ 25 135 114 2.7 ( 1.8,4.1) 2.9 ( 1.6, 5.1) 
Waist –to-hip ratio
≤ 0.95 52 137 1.0 1.0 
> 1.0 113 28 3.9 (2.1, 6.3) 2.8 (1.6, 5.7) 
Family history of MI
No 97 151 1.0 1.0 
Yes 62 14 2.1( 1.6, 2.7) 2.7 ( 1.8, 3.8) 
History of Hypertension
No 136 142 1.0 1.0 
Yes 29 23 2.1 ( 1.7, 3.2) 1.9 ( 1.4, 2.9) 
Education level
Highest level of education 25 27 1.0 1.0 
None 101 132 3.1 ( 1.3, 5.1) 3.6 (1.0, 6.2) 
Type of Family 
Split 20 64 1.0 1.0 
Joint 145 101 4.5 ( 1.5- 2.9) 3.9( 1.2-2.6) 
Civil Status 
Lower Class 10 19 1.0 1.0 
Middle Class 119 131 3.4 ( 4.3, 6.7) 2.8 ( 3.7, 5.9) 
Higher Class 36 15 4.7 ( 4.9, 7.2) 3.8 ( 3.1, 4.7) 
Leisure –time exercise
Non-exerciser 82 58 1.0 1.0 
≥ 145 MET-min/d 83 107 0.76 ( 0.4, 0.8) 0.68 (0.4, 0.7) 
Household income
>10 000 rupees/month 155 146 1.0 1.0 
<5000 rupees/month 10 19 1.8 ( 1.2, 2.7) 1.7 ( 1.0, 3.1) 
Hindu religion 
No 33 12 1.0 1.0 
Yes 132 153 0.8 (0.6, 1.1) 0.9 ( 0.7, 1.3) 
a MET, metabolic equivalent. RR estimates were obtained by using conditional logistic regression 
analysis controlled for the matching factors (age, sex, and hospital) and then additional potential risk 
factors.  
b Also adjusted for hospital.  
c Covariates controlled for in the multivariate model were as follows: age; sex; hospital; cigarette smoking   
never, current (≤10 cigarettes/d, >10 cigarettes/d)]; bidi smoking [never, current (≤10 bidis/d, >10 
bidis/d)]; BMI, in kg/m2 (20-24.9, ≥25); waist-to-hip ratio (≤0.95, >1.0); leisure time physical exercise (none, 
< 145 MET-min/d, ≤145 MET-min/d); history of hypertension (no, yes); history of diabetes (no, yes); 
history of high cholesterol (no, yes); family history of IHD (no, yes); education (none, primary school, 
middle, secondary, higher secondary, college, graduate or professional); household income (<5000, 5000-
10000, 10000-15000,>10000 rupees/mo); and Hindu religion (no, yes).  
* Bidis (pronounced bee-dees) are small hand-rolled cigarettes manufactured in India and other southeast 
Asian countries. They are exported to as many as 122 countries, according to one bidi manufacturer. Bidi 
cigarettes are made of tobacco wrapped in tendu or temburni leaf (Diospyros melanxylon). 
Table 6. Relative risk (RR) of Acute Myocardial Infarction (AMI) according to potential risk      
factorsa 
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 Control 
(n=165) 
AMI patients 
(n=165) 
P value (95%CI) 
Serum albumin ( mg/dl) 4.4 ± 0.3 4.2 ± 0.3 <0.001(4.17-4.28) 
Serum uric acid ( mg/dl) 5.8 ± 1.2 4.3 ± 0.9 <0.01(4.18-4.45) 
Serum ascorbic acid ( mg/dl) 5.3 ± 1.2 2.8 ± 0.7 <0.0001(2.70-2.89) 
Serum Total bilirubin ( mg/dl) 0.8 ± 0.2 0.7 ± 0.2 <0.001(0.62-0.69) 
Serum superoxide dismutase  
(U/gHb) 
1826.5 ± 31.9 813.9 ± 208.9 <0.02 (784.42-843.37) 
Serum glutathione peroxidase 
(U/gHb) 
61.3 ± 3.9 42.6 ± 6.3 <0.001(41.71- 43.48) 
Serum catalase (k/gHb) 256.2 ± 26.7 193.1 ± 35.9 <0.001(188.03-198.16) 
Serum Lipoprotein (a) (mg/dl) 3.0 ± 1.1 10.9 ± 2.2 <0.0001 (10.58-11.21) 
Serum malondialdehyde 
(nmol/L) 
5.7 ± 1.0 14.8 ± 1.7 <0.02(11.55-15.06) 
Serum conjugated dienes 
(µmol/L) 
31.0 ± 2.7 48.3 ± 5.5 <0.001(47.44-49.11) 
Table 7. Antioxidant status and Lipid Peroxidation in Control and AMI patients (mean ± SD)   
 
 Control 
(n=165) 
AMI patients 
(n=165) 
P value (95% CI) 
Plasma fibrinogen (mg/dl) 237.5 ± 17.4 357.8 ± 23.2 <0.0001 (354.52 -361.07 
Serum caeruloplasmin ( mg/dl) 20.4 ± 2.3 51.5 ± 2.4 <0.0001 (51.16-51.83) 
Serum Arylesterase activity ( 
kU/L) 
98.4 ± 6.2 69.7 ± 10.0 <0.0001(68.28-71.11) 
Serum Ischemia modified albumin 
(U/ml) 
81.9 ± 3.9 97.5 ± 11.7 <0.001(95.84-99.15) 
Serum C-reactive protein (mg/dl) 1.1 ± 0.3 3.0 ± 1.1 <0.0001(2.84-3.15) 
Table 8. Other Biochemical parameters in Control and AMI patients (mean ± SD)   
4. Dicussion 
Coronary artery disease (CAD) remains the major cause of morbidity and mortality in all 
developed and developing countries in the world including India (Reddy and Yusuf, 1998). 
Dyslipidemia is one of the major modifiable risk factors for CAD (Chopra et al, 1998; Vasisht 
et al, 2000; Malhotra et al, 2003).  
The coronary artery disease (CAD) risk factors do not predict the occurrence of acute 
myocardial infarction (AMI) as variation in risk factors is observed in South Asian 
population due to varied dietary habits and life style (Mishra et al, 2005). The search for 
various conventional risk factors among Asians could be helpful in recognizing the future 
events of stroke. These curiosities prompted us to identify the newer risk factors, with 
respect to Indian population. 
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The search for the newer risk factors continues and researchers are investigating the role of 
inflammatory markers and other potential risks factors which could link with acute 
myocardial infarction (AMI). 
In this prospective case-control study in India, only normolipidaemic acute myocardial 
infarction (AMI) patients were selected. The study was designed to identify and evaluate 
potential risk factors in normolipidaemic acute myocardial infarction (AMI) patients. The 
subjects selected for the study comprised of 165 controls, 48-69 y and 165 acute MI patients, 
48-69 y.  
Anthropometric variables in acute myocardial infarction (AMI) patients showed highly 
significant differences in waist/hip ratio and biceps skin fold thickness. Study reported 
(Heitman et al, 2004) that waist /hip ratio is a dominant, independent and predictive 
variable of cardiovascular disease and coronary heart disease deaths in Australian men and 
women. Megnien et al, 1999 also reported high hip circumference relative to weight and 
waist circumference is a better predictor of low incidence of cardiovascular disease and 
coronary heart disease. The present study is in good agreement with the observations of the 
above studies. Among Indians the cardiovascular risk is high even the prevalence of obesity 
is minimal (Megnien et al, 1999). In the present study the mean body mass index and waist 
/hip ratio in all subjects was 26.56 and 0.96 respectively, showing a significantly higher 
body mass index and weight /hip ratio in patients compared with control.  
Based on the observations of the aforementioned studies and further supported by the 
present study it could be concluded that weight/hip ratio is a better predictor of 
cardiovascular disease (CVD) than body mass index. So it is better tool for indentifying the 
future risk of acute myocardial infarction (AMI) in subjects by non-invasive procedures.  
Observations of lipid profile  
The mean total cholesterol level of the controls compared with acute myocardial infarction 
patients (186.44 ± 13.95 mg/dl) was significantly (p<0.001) higher compared with controls 
(168.58 ± 12.16 mg/dl). The mean high density lipoprotein-cholesterol level in the patients 
was significantly lower (p<0.001) compared with controls. Triglyceride (TG) values 
observed in acute myocardial infarction (AMI) patients was (129mg/dl) significantly higher 
than controls (107.8mg/dl). The mean low density lipoprotein-cholesterol (LDL-c) levels in 
patients was (119.4mg/dl) significantly higher than controls (83.6 mg/dl). The total 
cholesterol / high density lipoprotein – cholesterol ratio in acute myocardial infarct patients 
(4.6) was significantly (p<0.001) higher compared with controls (3.4). The present study 
observed significantly higher ratio (2.9) in acute myocardial infarction patients compared 
with control (1.9). 
Earlier studies in lipid profile analysis conducted on acute myocardial infarction patients  
(Mishra et al, 2001; Das et al, 2002; Goswami et al, 2003; Kharb et al, 2003; Malhotra et al, 2003; 
Burman et al, 2004; Rajashekhar et al, 2004; Sivaraman et al, 2004; Rani et al, 2005; Shindhe, et 
al, 2005; Yadhav et al, 2006; Patil et al, 2007) observed higher total cholesterol, triglyceride, 
low-density lipoprotein –cholesterol and lower levels of high-density lipoprotein-cholesterol 
in patients compared to controls. 
Also higher ratio of total cholesterol to high density lipoprotein-cholesterol, low-density 
lipoprotein-cholesterol to high-density cholesterol-lipoprotein and higher triglyceride to 
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high-density cholesterol-lipoprotein was observed in the present study. The present study 
concludes the importance of assessing the lipid ratios even in normolipidaemic subjects as it 
is one of the atherogenic factors for development of myocardial infarction and other 
coronary complications. The practice of computing the ratio should be implemented even in 
a normal health check up packages. In the final analysis it appears that myocardial 
infarction and coronary artery disease are not always associated with an elevated serum 
total cholesterol concentration. The major concern of this observation is that subjects who 
maintain desirable total cholesterol concentration also are targets for myocardial infarction 
(MI) and coronary artery disease (CAD) and therefore analysis of other risk factors that are 
non-conventional and newly emerging will be of immense important in the eventual 
assessment of the risk status. The existing literature and the results of the present study all 
point out that acute myocardial infarction and coronary artery disease patients have 
significantly higher total cholesterol concentration whether the values are in the desirable 
range or elevated. 
Antioxidant status  
The serum endogenous antioxidants were decreased in acute myocardial infarction 
compared to controls. Similarly the enzyme antioxidants were also significantly lowered in 
patients. 
Study conducted (Olusi et al, 1999; Djousse et al 2003) in acute myocardial infarction 
patients, reported significantly lower (p<0.0001) albumin and bilirubin (p<0.0001), where as 
lower levels of uric acid (Jing et al, 2000; Brand et al, 1985; Niskanen et al, 2004) and ascorbic 
acid (Nyossen et al, 1997; Bhakuni et al, 2006; Das et al, 2002; Kurl et al, 2002) in acute 
myocardial infarct patients were reported. 
The aforementioned studies suggested the expected risk of acute myocardial infarction is 
increased where these endogenous antioxidants are lowered due to enhanced utilization 
during oxidative stress in patients. Though, uric acid is well established antioxidant, but 
at times it can also act as a pro-oxidant, which might increase the risk of myocardial 
infarction. Aulinskas et al, (1983) established the role of ascorbic acid as up regulator of 
low density –lipoprotein (LDL) receptors, facilitating the clearance of low density –
lipoprotein (LDL). The low levels of ascorbic acid in acute myocardial infarction (AMI) 
patients in the present study might be due to enhanced utilization of ascorbic acid during 
oxidative stress in patients. 
The enzymatic antioxidants namely superoxide dismutase, catalase and glutathione 
peroxidase are also lowered in patients compared with controls. The findings of the present 
study concurs to earlier studies (Senthil et al, 2004; Bhakuni et al, 2006; Jain et al, 2000; 
Rajashekhar et al, 2004; Das et al, 2002; Gupta et al, 2006; Patil et al, 2007) where lower 
activities of superoxide dismutase, catalase and glutathione peroxidase. Studies conducted 
(Senthil et al, 2004; Shindhe et al, 2005; Rajasekhar et al, 2004; El-Badry et al, 1995; Gupta et al, 
2006 and Kharb 2003) also reported reduced activities of glutathione peroxidase in patients 
compared with controls. These studies are based on the hypothesis of decreased 
antioxidants due to oxidative insult in myocardial infarct patients. Thus it is indicative that 
low levels of both endogenous and enzyme antioxidants in circulation may be due to its 
increased utilization to scavenge toxic lipid peroxides.  
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Lipoprotein (a) and lipid peroxidation  
The mean serum Lipoprotein (a) malondialdehyde (MDA) and conjugated diene (CD) levels 
in MI patients were higher compared with controls. Earlier studies conducted (Burman et al, 
2004; Guha et al, 2001; Bal et al, 2001; Rajashekhar et al, 2004) also observed higher 
Lipoprotein (a) in AMI patients where as Nascetti et al, (1996) did not observed any change 
in Lipoprotein (a) levels in cardiovascular disease (CVD) patients and concluded lipoprotein 
(a) not to be considered as an independent risk factor in cardiovascular disease (CVD) 
patients.  
Studies conducted (Senthil et al, 2004; Das et al, 2002; Kharb 2003; Bhakuni et al, 2006; 
Shindhe et al, 2005; Gupta et al, 2006) reported higher levels of malondialdehyde (MDA) in 
myocardial infarct patients.  
Other biochemical parameters 
The levels of caeruloplasmin, C-reactive protein, fibrinogen, ischemia-modified albumin 
were higher and arylesterase activities were lowered in patients. Studies conducted 
(Grobusch et al, 1999; El-Badry et al, 1995; Giurgie, 2005; Awadallah et al, 2006) observed 
significantly higher (p<0.001) levels of caeruloplasmin where as (Berton et al, 2003; Bhagat et 
al, 2003; Sivaraman et al, 2004; Kulsoom et al, 2006; Boncler et al, 2006) observed higher levels 
of C-reactive protein in patients. Shukla et al, (2006) stated elevated levels of caeruloplasmin 
as a risk factor for acute myocardial infarct patients. The reactive oxygen species disrupts 
copper binding to caeruloplasmin thus impairing its antioxidant property and further 
promoting oxidative pathology. Studies conducted on plasma fibrinogen levels in acute 
myocardial infarct patients (Harkut et al, 2004; Coppola et al, 2005; Beg et al, 2007; Sivaraman 
et al, 2004) reported rise in plasma fibrinogen as the present study. Earlier study conducted 
(Chawla et al, 2006; Auxter, 2003; Bar-Or et al, 2001) in acute myocardial infarct patients also 
reported higher levels in patients as observed by the present study. Studies on arylesterase 
activities in acute myocardial infarct patients (Aviram et al, 1999; Ayub et al, 1999; Richard et 
al, 2000; Jarvik et al, 2002; Azizi et al, 2002; Singh et al, 2007; Sarkar et al, 2006) also observed 
lower activities as concurrent to the current study. Increased C-reactive protein (CRP) 
concentrations in patients with unstable angina and acute myocardial infarct might induce 
the production by the monocytes of the tissue factor which initiates the coagulation process. 
C-reactive protein together with fibrinogen acts as a chemotactic factor. Fibrinogen is 
responsible for the adhesion of macrophages to the endothelial surface for their migration 
into the intima. The elevated c-reactive protein levels have been found to be related to the 
occurrence of cardiovascular complications such as sudden cardiac death or AMI (Pepys 
and Hirschfield, 2003). 
Our study concluded apart from lipid profile, other variables which could be a probable risk 
for the future myocardial events have to be equally monitored. It is also recommended to 
increase dietary antioxidant intake in persons who already have known risk factors so that 
to some extent the myocardial infarction could be delayed. It is also important to check 
inflammatory markers like c-reactive protein and ischemia-modified albumin in a regular 
period of time after stepping early forties as they could be a cost effective mode of diagnosis 
and the subjects can be efficiently monitored and complications of myocardial infarction can 
be prolonged. 
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